ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, J. D.
Right arrow Articles by Robbins, R. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hill, J. D.
Right arrow Articles by Robbins, R. C.
Related Collections
Right arrow Mechanical Circulatory Assistance

Ann Thorac Surg 2001;71:S183-S184
© 2001 The Society of Thoracic Surgeons

Session 4: pulsatile implantable devices

Discussion of pulsatile implantable devices

J. Donald Hill, MD, Moderator, Laman A. Gray, Jr, MD, Panelist, Paul J. Hendry, MD, Panelist, James W. Long, MD, Panelist, Walter E. Pae, Jr, MD, Panelist, William S. Pierce, MD, Panelist, Robert C. Robbins, MD, Panelist

Presented at the Fifth International Conference on Circulatory Support Devices for Severe Cardiac Failure, New York, NY, Sept 15–17, 2000.

DR J. DONALD HILL (San Francisco, CA):

I have a question for Laman Gray and Bill Pierce. The total heart is on its way. And since you began this work many years ago, many more things have happened. I was wondering what class of patients you are anticipating to use the total heart on?

DR LAMAN A. GRAY, JR (Louisville, KY):

The initial group of patients who will be candidates for a total artificial heart will be patients who are not transplant candidates and who have end-stage cardiomyopathy with a life expectancy of less than 30 days. There will be no alternative therapies for this group of patients.

DR HILL:

But what about in terms of alternatives to other devices, you would see it crossing the line?

DR GRAY:

Initially the total artificial heart will be used in patients with biventricular failure rather than left ventricular failure. There are currently no other permanent implantable devices that can treat biventricular failure.

DR WILLIAM S. PIERCE . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.